Romosozumab After Denosumab Improves Lumbar Spine and Maintains Total Hip Bone Mineral Density in Postmenopausal Women with Low Bone Mass

被引：0

作者：

McClung, M. R. ^{[1
]}

Bolognese, M. A. ^{[2
]}

Brown, J. P. ^{[3
,4
]}

Reginster, J-Y ^{[5
]}

Langdahl, B. L. ^{[6
]}

Ruiz-Santiago, N. ^{[7
]}

Shi, Y. ^{[7
]}

Rojeski, M. ^{[7
]}

Timoshanko, J. ^{[8
]}

Libanati, C. ^{[8
]}

Kassahun, H. ^{[7
]}

Oates, M. ^{[7
]}

机构：

[1] Oregon Osteoporosis Ctr, Portland, OR USA

[2] Bethesda Hlth Res Ctr, Bethesda, MD USA

[3] Laval Univ, Quebec City, PQ G1K 7P4, Canada

[4] CHU Quebec CHUL, Res Ctr, Quebec City, PQ, Canada

[5] Univ Liege, Liege, Belgium

[6] Aarhus Univ Hosp, Aarhus, Denmark

[7] Amgen Inc, Thousand Oaks, CA 91320 USA

[8] UCB Pharma, Anderlecht, Belgium

来源：

JOURNAL OF BONE AND MINERAL RESEARCH | 2020年 / 35卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P-642

引用

下载

页码：246 / 247

页数：2

共 50 条

[41] Relationship between Carotid Atherosclerosis and Lumbar Spine Bone Mineral Density in Postmenopausal Women
Hiroyuki Sumino
Shuichi Ichikawa
Shu Kasama
Takashi Takahashi
Hironosuke Sakamoto
Hisao Kumakura
Yoshiaki Takayama
Tsugiyasu Kanda
Masami Murakami
Masahiko Kurabayashi
Hypertension Research, 2008, 31 : 1191 - 1197
[42] Effects of 2 Years of Treatment with Romosozumab Followed By 1 Year of Denosumab or Placebo in Postmenopausal Women with Low Bone Mineral Density.
McClung, M. R.
Chines, A.
Brown, J. P.
Diez-Perez, A.
Resch, H.
Caminis, J.
Bolognese, M. A.
Goemaere, S.
Bone, H. G.
Zanchetta, J. R.
Maddox, J.
Rosen, O.
Bray, S.
Grauer, A.
ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S406 - S407
[43] Changes in Lumbar Spine QCT, DXA, and TBS in Postmenopausal Women With Low Bone Mass Treated With Denosumab, Alendronate, or Placebo
Thomas, Thierry
Cheung, Angela M.
Shane, Elizabeth
Zanchetta, Jose R.
Kearns, Ann
Hans, Didier
Lin, Celia J. F.
Austin, Matthew
Libanati, Cesar
JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28
[44] Effect of Teprenone (GGA) with Etidronate(EHDP) on lumbar bone mineral density in postmenopausal women with low bone mineral density
Shintani, M
Beppu, K
Hara, Y
BONE, 2003, 32 (05) : S209 - S209
[45] BONE MINERAL DENSITY IN POSTMENOPAUSAL WOMEN WITH HIP OSTEOARTHRITIS
Grygorieva, N.
Povoroznyuk, V.
Krochak, S.
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 1068 - 1068
[46] Bone mineral density in postmenopausal women with hip osteoarthritis
Grygorieva, N.
Povoroznyuk, V.
Krochak, S.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2014, 43 : 36 - 37
[47] The rank ligand inhibitor denosumab (AMG 162) increases bone mineral density in postmenopausal women with low bone mass after 2 years of treatment
Lewiecki, E. M.
Miller, P. D.
McClung, M. R.
Cohen, S. B.
Lu, Y.
Wang, A.
Fitzpatrick, L. A.
ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 80 - 80
[48] IMPACT OF ROMOSOZUMAB ON BONE MINERAL DENSITY IN POSTMENOPAUSAL OSTEOPOROSIS
Azharuddin, M.
Sharma, M.
AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 34 (SUPPL 1) : S425 - S425
[49] Impact of romosozumab on bone mineral density in postmenopausal osteoporosis
Azharuddin, Md
Sharma, Manju
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 330 - 330
[50] Exercises aimed to maximize lean mass and bone mineral density at the hip and lumbar spine
Nguyen, Vu H.
OSTEOPOROSIS AND SARCOPENIA, 2021, 7 (01) : 42 - 43

← 1 2 3 4 5 →